HIV drugs

Overcoming Barriers to Adherence in HIV: A Case for an Innovative Approach to Treatment

Innovation in the HIV treatment landscape is playing a role in addressing medication adherence. In recent years, long-acting injectable antiretroviral monthly and bi-monthly treatment options have been approved – a welcome alternative for people living with HIV. We are now on the cusp of it coming full circle from the days when patients took multiple pills a day to potentially a one-and-done single-dose treatment

By Marcus Conant

BioPharma, Pharma

J&J Stops Work on HIV Vaccine After Failure in Phase 3 Clinical Trial

Johnson & Johnson is stopping clinical development of an experimental HIV vaccine after the four-shot regimen did not beat a placebo in a late-stage study. The clinical trial failure comes follows the 2021 failure of the vaccine candidate in a different study population.

By Frank Vinluan

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.

BioPharma, Pharma

Merck HIV drug trials paused by FDA will resume under modified plan

A Merck HIV drug placed under multiple full and partial clinical holds last year is now clear to resume testing. As part of a modified plan, Merck will test a lower dose of its experimental drug, islatravir. The pharma giant is also dropping tests of the drug for HIV prevention.

By Frank Vinluan

Legal, Payers

Humana, Centene file antitrust suit against Gilead for HIV drug agreements

The insurers referred to deals Gilead struck with Janssen, Bristol Myers Squibb to prevent the generic version of its retroviral medications from being used as part of combination treatments. They also allege the company struck a deal with Teva to delay the release of its generic drug.

By Elise Reuter

Hospitals

Advocates accuse insurers of discriminating with high cost-sharing for chronic disease drugs

Four Florida insurers allegedly discriminate against people with HIV/AIDS by structuring their prescription drug benefits so that patients are discouraged from enrolling, according to a recent complaint filed with federal officials. The complaint, filed with the Office for Civil Rights at the federal Department of Health and Human Services, claims that the insurers—CoventryOne, Cigna, Humana and Preferred Medical—violated the […]

By Michelle Andrews